Patients with active or refractory SLE commonly exhibit elevated IL-6 levels, accompanied by increased numbers and persistent tissue infiltration of activated CD4+ and CD8+ T cells, as well as myeloid cells. Here, IL6 is linked to systemic lupus erythematosus.